Background and Purpose— Cognitive impairment occurs in ≤30% of all stroke survivors.
However, effective therapies aimed at preventing poststroke cognitive decline are lacking. We …

Clinical 123 I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane ( 123 I-FP-CIT)
SPECT studies are commonly performed and reported using visual evaluation of tracer …

Background There is a lack of knowledge of disease course, prognosis, comorbidities and
potential treatments of elderly MS patients. Objective To characterize the disease course …

The human brain exhibits marked hemispheric differences, though it is not fully understood
to what extent lateralization of the epileptic focus is relevant. Preoperative [ 18 F]FDG-PET …

Background Cognitive impairment after stroke is a considerable burden to patients and their
caregivers and occurs in one-third of stroke survivors. No strategy to prevent cognitive …

… , Karin Zebenholzer, Fritz Leutmezer, Gudrun Zulehner, Karl Vass and Susanne
Asenbaum-Nan ∗ … Tel.: +43 1 40400 3117; Fax: +43 1 40400 3141; E-mail: Susanne.asenbaum-nan@…

Background and objectives Differences in stroke risk factors and treatment variables between
rural and urban regions in Austria were analyzed retrospectively as European data on this …

The increasing burden of stroke and dementia emphasizes the need for new, well-tolerated
and cost-effective primary prevention strategies that can reduce the risks of stroke and …

Background and aim Behavioral and lifestyle interventions in stroke patients need to be intense
enough to result in sustainable treatment differences among groups of a randomized trial…

Background The effect of early blood pressure reduction on cognitive function in patients
with acute ischemic stroke remains unknown. Aim We tested whether antihypertensive …